The tsRNA tsr007330 is significantly downregulated after MI, and by antagonizing N-acetyltransferase NAT10, it inhibits the ac4C modification of early growth response protein 3 (EGR3) mRNA mediated by NAT10, thereby reducing myocardial fibrosis and improving cardiac function. The gene discussed is EGR3; the disease is myocardial infarction.